Australia’s medicinal cannabis sector is evolving and so are patient expectations.

With patients becoming more informed, more selective, and more willing to change providers if their experience doesn’t meet expectations.In our latest blog, Medicinal Cannabis Patients: Preferences & Perspectives, we explore what patients actually value today and the trends clinics should be preparing for as the market continues to mature.

Whether you're a clinic operator, healthcare professional, or industry stakeholder, understanding these shifts is key to building sustainable, patient-centred care models.

Understanding the patient pathway to medicinal cannabis in Australia can be a major hurdle for businesses . 
Our latest blog post breaks down the entire journey from clinical assessment to TGA approval, highlighting the critical operational frameworks businesses need to support Australian patients effectively.

This article explores the role of pharmacists in dispensing medicinal cannabis, with a focus on patient access, continuity of care, and quality oversight.

Medicinal cannabis in Australia is rapidly evolving — where what was once a niche market is now a significant part of modern healthcare. For businesses navigating this landscape, understanding these dual pressures is key to thriving in this fast-paced and dynamic environment.

Explore the key rules from governing regulators as it relates to advertising within the medicinal cannabis space to, clarify what clinics and brands can and cannot say, alongside safer strategies to build awareness without risking compliance.

Registered nurses with appropriate training and experience will be able to prescribe medicinal cannabis under a collaborative prescribing model. In this post, we explore how this change brings unprecedented opportunity and responsibility.

In the latest addition to our Market Insights series that explores the Australian medicinal cannabis space, we look into patient demographics and how patients access plant-based medicines.

We sat down with industry trailblazer, Irena Katz of We Are Lux, to discuss her journey within the medicinal cannabis industry as a qualified naturopath and passionate cannabis advocate. In this post, we explore how Irena's personal experience, purpose, and bold vision has made her a strong patient advocate and industry innovator — and how these qualities have also helped shape her store We Are Lux.

For businesses looking to enter or maximise their presence within the medicinal cannabis market, understanding the evolving prescriber landscape and access pathways is crucial to navigate this dynamic market effectively.

Since its legalisation for therapeutic use, Australia’s medicinal cannabis industry has rapidly evolved, marked by complex regulatory changes and a growing infrastructure — making it essential for industry stakeholders to understand the journey of legalisation, its impact on Australian patients, and the diverse ecosystem of stakeholders working to expand access and challenge the lingering stigma surrounding medicinal cannabis.

For healthcare practitioners prescribing or dispensing medicinal cannabis in Australia, it’s essential to understand the varying regulations that can impact patient outcomes — including dispensing substitution policies for these medications.